Literature DB >> 17143007

Long-term mortality, morbidity and hospital care following intracerebral hemorrhage: an 11-year cohort study.

Alistair J McGuire1, Maria Raikou, Ian Whittle, Michael C Christensen.   

Abstract

BACKGROUND AND
PURPOSE: Intracerebral hemorrhage (ICH) represents the severest form of stroke, yet examinations of long-term prognosis and associated health care use are rare. This study assessed survival, morbidity and cost of hospital care over 11 years following a first-ever ICH in the UK.
METHODS: We used a population-based retrospective inception cohort design using data from the Hospital Record Linkage System in Scotland. Long-term survival, morbidity and treatment provided in hospitals were evaluated in all patients with a first diagnosis of ICH in 1995. A cohort of ischemic stroke (IS) patients was also examined for comparison.
RESULTS: A total of 705 patients with ICH and 8,893 with IS were identified. The mean age was 65 years (SD = 17.2) for ICH and 73 years (SD = 11.8) for IS at stroke onset. The acute in-hospital mortality was 45.7 and 30.1% for ICH and IS, 51.2 and 39.9% at 1 year, while 76.0 and 80.4% were dead 11 years later. The cumulative risk of nonfatal or fatal ICH was 8.0, 12.7 and 13.7% at 1, 5 and 10 years, and 7.0, 11.1 and 12.9% for IS in the ICH cohort. The mean cost of initial hospital care was GBP 10,332 (SD = 19,919) for ICH and GBP 9,937 (SD = 15,777) for IS. The mean total costs over 11 years were GBP 18,629 (SD = 29,943) for ICH and GBP 21,505 (SD = 27,190) for IS.
CONCLUSION: Following a first ICH, individuals have a poorer short-term prognosis than individuals with IS, yet both ICH and IS imply significant follow-up care.

Entities:  

Mesh:

Year:  2006        PMID: 17143007     DOI: 10.1159/000097645

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  7 in total

1.  Upper extremity recovery after ischaemic and haemorrhagic stroke: Part of the SALGOT study.

Authors:  Hanna C Persson; Arve Opheim; Åsa Lundgren-Nilsson; Margit Alt Murphy; Anna Danielsson; Katharina S Sunnerhagen
Journal:  Eur Stroke J       Date:  2016-10-17

Review 2.  Patient-level costs of major cardiovascular conditions: a review of the international literature.

Authors:  Gina Nicholson; Shravanthi R Gandra; Ronald J Halbert; Akshara Richhariya; Robert J Nordyke
Journal:  Clinicoecon Outcomes Res       Date:  2016-09-21

3.  Stereotactic Administration of Edaravone Ameliorates Collagenase-Induced Intracerebral Hemorrhage in Rat.

Authors:  Yan Zhang; Yang Yang; Guang-Zhu Zhang; Mou Gao; Guang-Zhi Ge; Qin-Qin Wang; Xin-Chao Ji; Yi-Lin Sun; Hong-Tian Zhang; Ru-Xiang Xu
Journal:  CNS Neurosci Ther       Date:  2016-07-08       Impact factor: 5.243

Review 4.  Systematic Review of Hospital Readmissions in Stroke Patients.

Authors:  Ahsan Rao; Emily Barrow; Sabine Vuik; Ara Darzi; Paul Aylin
Journal:  Stroke Res Treat       Date:  2016-09-07

5.  Secondary prophylactic treatment and long-term prognosis after TIA and different subtypes of stroke. A 25-year follow-up hospital-based observational study.

Authors:  Sven-Erik Eriksson
Journal:  Brain Behav       Date:  2016-11-28       Impact factor: 2.708

6.  Long-term prognosis after intracerebral haemorrhage.

Authors:  Koen M van Nieuwenhuizen; Ilonca Vaartjes; Jamie I Verhoeven; Gabriel Je Rinkel; L Jaap Kappelle; Floris Hbm Schreuder; Catharina Jm Klijn
Journal:  Eur Stroke J       Date:  2020-09-02

7.  Cost-effectiveness of treating resistant hypertension with an implantable carotid body stimulator.

Authors:  Kate C Young; J C Teeters; Curtis G Benesch; John D Bisognano; Karl A Illig
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-10       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.